Current Opinion in Endocrinology Diabetes and Obesity

Papers
(The median citation count of Current Opinion in Endocrinology Diabetes and Obesity is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Maximizing diabetes education efforts in vulnerable populations – newer delivery concepts32
Public health concerns and increased risk of severe COVID-19 disease through androgen use30
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?29
The therapeutic properties of ketogenic diets, slow-wave sleep, and circadian synchrony27
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and thyroid disease. An update27
The female athlete triad: review of current literature22
Updates in thyroid healthcare delivery: advancing patient-centered care22
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome22
Advances in the care of lipodystrophies21
Advances in assessment and treatment of bone, mineral and parathyroid disorders20
Editorial introduction20
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health20
Nutrition and thyroid disease20
International patient group harnesses social media to help inform rare disease research: use of a low carbohydrate ketogenic diet in McArdle disease19
Recent advances in anaplastic thyroid cancer management18
Editorial18
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?17
Editorial introductions17
Financial toxicity in thyroid cancer survivors17
Appropriate selection of candidates for outpatient thyroidectomy17
Harm reduction strategies for androgen users: providing appropriate support and improving engagement with healthcare16
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis16
Interactions between antidiabetes medications and heart–brain axis16
Medullary thyroid carcinoma16
Editorial introduction15
Preventing type 1 diabetes development and preserving beta-cell function15
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency15
Update on fracture risk assessment in osteoporosis14
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?14
An update on bone in diabetes14
Gastrointestinal hormones and regulation of gastric emptying14
The use of anabolic agents in the treatment of osteoporosis: a clinical update14
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks13
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia13
Lipidomics in diabetes13
Long-acting amylin analogues for the management of obesity12
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease12
Fibrous dysplasia in children and its management12
Epidemiologic changes in thyroid disease12
Assisted reproductive technology outcomes and management considerations for people with epilepsy11
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders11
Precision medicine in diabetes care11
The uncommon forms of congenital adrenal hyperplasia10
Growth and development in type 1 diabetes10
A short history of saturated fat: the making and unmaking of a scientific consensus10
Type 2 diabetes: a contemporary view from the Asian lens10
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease10
Legislation, medicine, and politics: care for gender diverse youth9
Editorial introductions9
Effects of marijuana on reproductive health: preconception and gestational effects9
An update on investigation and management of renal bone disease9
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation9
Editorial introductions9
Glucocorticoid withdrawal syndrome: what to expect and how to manage9
Adrenal insufficiency and pregnancy9
Retrospective cohort study of changes in estimated glomerular filtration rate for patients prescribed a low carb diet9
An Update on Vitamin D Deficiency in the twenty-first century: nature and nurture8
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment8
Early anthropometric indicators of type 2 diabetes mellitus8
Novel techniques for assessment of bone tissue material properties8
Editorial introductions8
The interaction between gut microbiome and bone health7
Multifactorial chylomicronemia syndrome7
Time to cycle regularity and health risks7
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety7
Androgen abuse among gay and bisexual men7
Survival benefit of endocrine dysfunction following immune checkpoint inhibitors for nonthyroidal cancers7
Indications for testosterone therapy in men7
Novel delivery mechanisms for antigen-specific immunotherapy6
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective6
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?6
Advanced imaging and theranostics in thyroid cancer6
Microplastics, cardiometabolic risk, genetics and Alzheimer's disease6
Hypophysitis from immune checkpoint inhibitors: challenges in diagnosis and management6
Polygenic risk scores for the diagnosis and management of dyslipidemia6
Continuous glucose monitoring in primary care – are we there?6
Type 2 diabetes mellitus and cognitive function: understanding the connections6
Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases6
The psychosocial impact of thyroid cancer5
Bridging the LatinX community care gap5
Radiofrequency ablation (RFA) compared to observation for benign thyroid nodules: emerging considerations for judicious use5
HDL functionality in type 1 and type 2 diabetes: new insights5
Editorial introductions5
When history, law, and medicine intersect5
Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials5
Skeletal health in diabetes5
Current state of antigen-specific immunotherapy for type 1 diabetes5
Editorial introductions5
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome5
Predictors of cardiovascular risk in familial hypercholesterolemia5
Gastrointestinal regulatory peptides5
Preconception health optimization in women with polycystic ovary syndrome − how to find the time?4
Bone marrow adiposity in diabetes and clinical interventions4
Prediabetes and skeletal health4
Fracture prediction tools in diabetes4
Editorial: New horizons for thyroid diseases: transformative changes and tailored care4
Utilizing point-of-care A1c to impact outcomes – can we make it happen in primary care?4
Mixed-methods research on androgen abuse – a review4
Glutamic acid decarboxylase immunotherapy for type 1 diabetes4
Aggression and criminality in androgen abusers4
Nutritional ketosis is well-tolerated, even in type 1 diabetes: the ZeroFive100 Project; a proof-of-concept study4
Potassium-competitive acid blockers and acid-related disorders4
Recent advances in the role of miRNAs in bone disease4
Growth and development in monogenic forms of neonatal diabetes3
Hypoparathyroidism update3
Body composition in sexual precocity3
Emerging treatment for congenital adrenal hyperplasia3
Better care for women with polycystic ovary syndrome – a proposal for an international evidence based best practice framework to improve care3
Editorial: Childhood endocrine and genetic disorders: improving adult outcomes3
Biomarkers in gastroenteropancreatic neuroendocrine neoplasms3
Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?3
An update: maternal iodine supplementation, thyroid function tests, and child neurodevelopmental outcomes3
Update on management of paediatric dyslipidaemia3
Editorial introductions3
Cardiovascular disease in metabolic-associated fatty liver disease3
Overview of diabetes agents in cardiovascular disease: it takes an orchestra to play Tchaikovsky in symphony3
Glucagon-like peptide-1 receptor agonists and safety in the preconception period3
Enteroendocrine cell differentiation and function in the intestine2
GLP-1RA based therapies in the young and old2
Ketogenic diet as an advanced option for the management of pediatric obesity2
Molecular tools for diagnosing diseases of the adrenal cortex2
Editorial introduction2
Selective progesterone receptor modulators and reproductive health2
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?2
Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome2
Health effects of androgen abuse: a review of the HAARLEM study2
Use of calculated free testosterone in men: advantages and limitations2
Editorial introductions2
An overview of persistent chylomicronemia: much more than meets the eye2
Editorial introduction2
Addressing genetic and environmental sources of cardiometabolic disease2
Editorial overview2
Eicosapentaenoic acid vs. docosahexaenoic acid for the prevention of cardiovascular disease2
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia2
Acromegaly: achieving timely diagnosis and improving outcomes by personalized care2
Differences in the management of thyroid nodules in children and adolescents as compared to adults2
Editorial introductions2
Hypertriglyceridemia: rationale, design and implementation of the Australian Hypertriglyceridemia Registry2
Effects of diabetes on osteocytes2
Under and overtreatment with thyroid hormone replacement during pregnancy2
Molecular testing for indeterminate thyroid nodules: past, present, and future2
Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes2
Effect of incretins on skeletal health2
Mouse models of type 1 diabetes and their use in skeletal research2
Benefits and risks of apps for patients2
0.066772222518921